Jiangsu Cancer Hospital ( Site 2432)

Nanjing, Jiangsu 210009

0 studies enrolling now · 2 studies all time

What they study most

Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma, Stomach Neoplasms

Studies at this site

• Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) — Completed
• Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811) — Completed